Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule

Biotechnology and Bioengineering

Volumn 104, Issue 1, 2009, Pages 206-215

  Froelich, Steven ^a   Ziegler, Leslie ^a   Stroup, Katie ^a   Wang, Pin ^a  

^a HED 216 ^*  (United States)

Author keywords

c KIT receptor; Gene therapy; Lentivirus; Targeted gene delivery

Indexed keywords

ANTIBODY-ANTIGEN INTERACTIONS; C-KIT RECEPTOR; CELL TYPES; EFFICIENT METHOD; GENE DELIVERY; GENE THERAPY; IN-VITRO; IN-VIVO; LENTIVIRAL VECTOR; LENTIVIRUS; MEMBRANE-BOUND; MOUSE MODELS; NATURAL LIGANDS; RECOGNITION MECHANISM; SIDE EFFECT; SPECIFIC SURFACE; STEM CELL FACTOR; TARGET CELLS; TARGETED GENE DELIVERY; THERAPEUTIC EFFECTS;

ANTIBODIES; BIOACTIVITY; CYTOLOGY; GENE EXPRESSION; GENE TRANSFER; INTERNET; TARGETS;

CELL MEMBRANES;

LENTIVIRUS VECTOR; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE FUSION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; SINDBIS VIRUS; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-KIT; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; SINDBIS VIRUS; STEM CELL FACTOR; TRANSDUCTION, GENETIC; VIRUS INTERNALIZATION;

LENTIVIRUS; SINDBIS VIRUS;

EID: 69249084080     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22378     Document Type: Article

References (35)

1. Aires da Silva F, Costa MJ, Corte-Real S, Goncalves J. 2005. Cell typespecific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies. Hum Gene Ther 16(2):223-234. (Pubitemid 40344214)
2. Akporiaye ET, Hersh E. 1999. Clinical aspects of intratumoral gene therapy. Curr Opin Mol Ther 1(4):443-453. (Pubitemid 29420039)
3. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Le Deist F, Fischer A. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288(5466):669-672. (Pubitemid 30241569)
4. Cetin N, Dienel G, Gokden M. 2005. CD117 expression in glial tumors. J Neurooncol 75(2):195-202.
5. Chandrashekran A, Gordon MY, Casimir C. 2004. Targeted retroviral transduction of c-kit+ hematopoietic cells using novel ligand display technology. Blood 104(9):2697-2703. (Pubitemid 39434950)
6. Chapel A, Poncet P, Neildez-Nguyen TM, Vetillard J, Brouard N, Goupy C, Chavanel G, Hirsch F, Thierry D. 1999. Targeted transfection of the IL- 3 gene into primary human hematopoietic progenitor cells through the c-kit receptor. Exp Hematol 27(2):250-258. (Pubitemid 29131736)
7. Chapel A, Deas O, Bensidhoum M, Francois S, Mouiseddine M, Poncet P, Durrbach A, Aigueperse J, Gourmelon P, Gorin NC, et al. 2004. In vivo gene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene delivery. Genet Vaccines Ther 2(1):16.
8. Duensing A, Heinrich MC, Fletcher CD, Fletcher JA. 2004. Biology of gastrointestinal stromal tumors: KIT mutations and beyond. Cancer Invest 22(1):106-116. (Pubitemid 38523964)
9. Edling CE, Hallberg B. 2007. c-Kit-a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol 39(11):1995-1998. (Pubitemid 47376824)
10. Fielding AK, Maurice M, Morling FJ, Cosset FL, Russell SJ. 1998. Inverse targeting of retroviral vectors: Selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. Blood 91(5):1802-1809. (Pubitemid 28110348)
11. Gollan TJ, Green MR. 2002. Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands. J Virol 76(7):3564-3569.
12. Hamel W, Westphal M. 1997. The road less travelled: c-kit and stem cell factor. J Neurooncol 35(3):327-333. (Pubitemid 27511135)
13. Itoh A, Okada T, Mizuguchi H, Hayakawa T, Mizukami H, Kume A, Takatoku M, Komatsu N, Hanazono Y, Ozawa K. 2003. A soluble CARSCF fusion protein improves adenoviral vector-mediated gene transfer to c-Kit-positive hematopoietic cells. J Gene Med 5(11):929-940. (Pubitemid 40310418)
14. Jang JH, Lim KI, Schaffer DV. 2007. Library selection and directed evolution approaches to engineering targeted viral vectors. Biotechnol Bioeng 98(3):515-524.
15. Joo KI, Wang P. 2008. Visualization of targeted transduction by engineered lentiviral vectors. Gene Ther 15(20):1384-1396.
16. Kasahara N, Dozy AM, Kan YW. 1994. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266(5189):1373-1376.
17. Kueng HJ, Leb VM, Haiderer D, Raposo G, Thery C, Derdak SV, Schmetterer KG, Neunkirchner A, Sillaber C, Seed B, et al. 2007. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol 81(16):8666-8676. (Pubitemid 47242840)
18. Logan AC, Lutzko C, Kohn DB. 2002. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr Opin Biotechnol 13(5):429-436. (Pubitemid 35379927)
19. Lu YE, Cassese T, Kielian M. 1999. The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virol 73(5):4272-4278. (Pubitemid 29189873)
20. Lutzko C, Senadheera D, Skelton D, Petersen D, Kohn DB. 2003. Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes. J Virol 77(13):7341-7351. (Pubitemid 36734502)
21. Mellman I, Fuchs R, Helenius A. 1986. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 55:663-700.
22. Miettinen M, Lasota J. 2005. KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 13(3):205-220. (Pubitemid 41209013)
23. Moreau T, Bardin F, Imbert J, Chabannon C, Tonnelle C. 2004. Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells. Mol Ther 10(1):45-56. (Pubitemid 38878148)
24. Morita E, Sundquist WI. 2004. Retrovirus budding. Annu Rev Cell Dev Biol 20:395-425.
25. Morizono K, Xie Y, Ringpis GE, Johnson M, Nassanian H, Lee B, Wu L, Chen IS. 2005. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med 11(3): 346-352. (Pubitemid 40460565)
26. Sandrin V, Russell SJ, Cosset FL. 2003. Targeting retroviral and lentiviral vectors. Curr Top Microbiol Immunol 281:137-178.
27. Schwarzenberger P, Spence SE, Gooya JM, Michiel D, Curiel DT, Ruscetti FW, Keller JR. 1996. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 87(2):472-478. (Pubitemid 26030302)
28. Szymczak AL, Vignali DA. 2005. Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin Biol Ther 5(5):627-638. (Pubitemid 40780547)
29. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs SV, Martin FH, Williams DA. 1992. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 89(16): 7350-7354.
30. Verma IM, Weitzman MD. 2005. Gene therapy: Twenty-first century medicine. Annu Rev Biochem 74:711-738.
31. Waehler R, Russell SJ, Curiel DT. 2007. Engineering targeted viral vectors for gene therapy. Nat Rev Genet 8(8):573-587. (Pubitemid 47077278)
32. Yang L, Bailey L, Baltimore D, Wang P. 2006. Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci USA 103(31):11479-11484. (Pubitemid 44182477)
33. Yang H, Ziegler L, Joo KI, Cho T, Lei Y, Wang P. 2008. Gamma-retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen-specific targeting. Biotechnol Bioeng 101 (2):357-368.
34. Zhao Y, Zhu L, Lee S, Li L, Chang E, Soong NW, Douer D, Anderson WF. 1999. Identification of the block in targeted retroviral-mediated gene transfer. Proc Natl Acad Sci USA 96(7):4005-4010. (Pubitemid 29169026)
35. Zhong Q, Oliver P, Huang W, Good D, La Russa V, Zhang Z, Cork JR, Veith RW, Theodossiou C, Kolls JK, et al. 2001. Efficient c-kit receptortargeted gene transfer to primary human CD34-selected hematopoietic stem cells. J Virol 75(21):10393-10400. (Pubitemid 32948069)